Cost-Effectiveness of Two Painkillers for Treating Pain After Limb Injuries: Randomised Controlled Trial
Information source: Chinese University of Hong Kong
Information obtained from ClinicalTrials.gov on November 03, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Soft Tissue Injuries
Intervention: Paracetamol (Drug); Ibuprofen (Drug); Paracetamol Placebo (Drug); Ibuprofen placebo (Drug)
Phase: Phase 2
Status: Recruiting
Sponsored by: Chinese University of Hong Kong Official(s) and/or principal investigator(s): Colin A Graham, Principal Investigator, Affiliation: Chinese University of Hong Kong
Overall contact: Colin A Graham, Phone: 85-22-632-1033, Email: cagraham@cuhk.edu.hk
Summary
Background: Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen
are commonly used oral analgesics in emergency departments (ED) not only in Hong Kong but
throughout the world. There are no large-scale (n>100), prospective, randomised studies
comparing paracetamol with ibuprofen in the management of acute soft tissue injury.
As paracetamol is cheaper than most NSAIDs, may be as effective in the management of acute
pain and possibly with fewer adverse effects, a large-scale, randomised, controlled trial is
needed to answer questions of relative analgesic efficacy, safety and cost-effectiveness.
Previous comparative studies on NSAIDS have been done in this unit and have suggested
equivalence between two NSAIDs and paracetamol, but numbers were small and drug doses were
modest.
Objective: To compare the efficacy, safety and cost between oral ibuprofen and paracetamol
in pain control for acute soft tissue injuries in an ED setting
Design: Prospective, double-blind, randomised controlled trial with three arms: oral
paracetamol with placebo; oral ibuprofen with placebo; paracetamol and ibuprofen in
combination
Participants: 783 subjects having sustained isolated soft tissue limb injury without
significant fracture presenting to the ED of Prince of Wales Hospital
Main outcome measures: Pain relief profiles of paracetamol, ibuprofen and the combination of
both; adverse effect profiles of paracetamol, ibuprofen and the combination of both; overall
cost effectiveness of paracetamol, ibuprofen and the combination of both from the perspective
of the healthcare provider
Clinical Details
Official title: Cost-Effectiveness Analysis of Oral Paracetamol and Ibuprofen for Treating Pain After Soft Tissue Limb Injuries: Double-Blind, Randomised Controlled Trial
Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Single Group Assignment, Efficacy Study
Primary outcome: analgesic efficacy both at rest and with movement
Secondary outcome: presence, frequency and duration of adverse effects; cost-effectiveness analysis; patient satisfaction with analgesia
Eligibility
Minimum age: 16 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- All patients >16 years presenting to the ED with isolated soft tissue injury without
significant fracture
- between 9am to 5pm, Monday to Friday,
Exclusion Criteria:
- History of :
- peptic ulceration or hemorrhage
- recent anticoagulation
- pregnancy
- adverse reaction to paracetamol or ibuprofen
- renal or cardiac failure
- hepatic problems
- rectal bleeding
- chronic NSAID consumption
- asthma
- chronic obstructive pulmonary disease
- chronic pain syndromes
- prior treatment with analgesia for the same injury
- physical, visual or cognitive impairment making use of the visual analogue scale
unreliable
Locations and Contacts
Colin A Graham, Phone: 85-22-632-1033, Email: cagraham@cuhk.edu.hk
Prince of Wales Hospital, Sha Tin, NT, Hong Kong; Recruiting Colin A Graham, Principal Investigator
Additional Information
Starting date: January 2005
Ending date: December 2008
Last updated: May 8, 2008
|